Furthermore, in silico analysis of scRNA-seq data of glioma tumours, we found that AKT2 expression is highest in the malignant tumour cells themselves when compared to the immune and stromal populations (Figure 3(B,C)). The gene discussed is AKT2; the disease is central nervous system cancer.